Latest filings (excl ownership)
DEFR14A
Revised proxy
29 Apr 24
8-K
Corporate Presentation April 2024
9 Apr 24
ARS
2023 FY
Annual report to shareholders
1 Apr 24
DEFA14A
Additional proxy soliciting materials
1 Apr 24
DEF 14A
Definitive proxy
1 Apr 24
PRE 14A
Preliminary proxy
22 Mar 24
8-K
Departure of Directors or Certain Officers
21 Mar 24
8-K
Departure of Directors or Certain Officers
11 Mar 24
S-8
Registration of securities for employees
29 Feb 24
10-K
2023 FY
Annual report
29 Feb 24
8-K
Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results
29 Feb 24
8-K
Quantum-Si Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing™ Platform
5 Feb 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
8-K
Quantum-Si Reports Third Quarter 2023 Financial Results
9 Nov 23
8-K
Quantum-Si Appoints Biotech Executive and Entrepreneur, Amir Jafri, to its Board of Directors
21 Sep 23
8-K
Departure of Directors or Certain Officers
5 Sep 23
8-K
Cost Associated with Exit or Disposal Activities
29 Aug 23
EFFECT
Notice of effectiveness
23 Aug 23
CORRESP
Correspondence with SEC
18 Aug 23
UPLOAD
Letter from SEC
18 Aug 23
S-3
Shelf registration
11 Aug 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
8-K
Quantum-Si Reports Second Quarter 2023 Financial Results
7 Aug 23
S-8
Registration of securities for employees
20 Jul 23
8-K
Departure of Directors or Certain Officers
19 Jul 23
8-K
Quantum-Si Announces the Appointment of Industry Veteran Johan Denecke as Senior Vice President of Operations
21 Jun 23
8-K
Departure of Directors or Certain Officers
7 Jun 23
8-K
Quantum-Si Appoints Life Sciences and Diagnostics Industry Leader Jack Kenny to its Board of Directors
22 May 23
8-K
Amendments to Articles of Incorporation or Bylaws
16 May 23
10-Q
2023 Q1
Quarterly report
11 May 23
8-K
Quantum-Si Reports First Quarter 2023 Financial Results
11 May 23
8-K
Quantum-Si Announces the Appointment of Jeff Keyes as Chief Financial Officer
2 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Mar 23
DEF 14A
Definitive proxy
29 Mar 23
PRE 14A
Preliminary proxy
17 Mar 23
S-8
Registration of securities for employees
16 Mar 23
10-K
2022 FY
Annual report
16 Mar 23
8-K
Other Events
15 Mar 23
8-K
Regulation FD Disclosure
13 Mar 23
Latest ownership filings
4
Paula Dowdy
25 Mar 24
3
Paula Dowdy
25 Mar 24
4
Jeffry R. Keyes
18 Mar 24
4
Jeffrey Alan Hawkins
18 Mar 24
4
Grace Johnston
18 Mar 24
4
Christian LaPointe
18 Mar 24
4
Jeffry R. Keyes
6 Mar 24
SC 13G
Nikko Asset Management Americas, Inc.
13 Feb 24
SC 13G
Sumitomo Mitsui Trust Holdings, Inc.
5 Feb 24
SC 13G/A
BlackRock Inc.
29 Jan 24
SC 13G/A
ARK Investment Management LLC
29 Jan 24
4
Amir Jafri
26 Sep 23
3
Amir Jafri
26 Sep 23
SC 13D/A
ROTHBERG JONATHAN M
13 Sep 23
144
Notice of proposed sale of securities
28 Jul 23
144
Notice of proposed sale of securities
19 Jul 23
SC 13G/A
ARK Investment Management LLC
10 Jul 23
3
John P. Kenny
24 May 23
4
John P. Kenny
24 May 23
4
Ruth A Fattori
16 May 23
4
KEVIN RAKIN
16 May 23
4
JONATHAN M ROTHBERG
16 May 23
4
Brigid Makes
16 May 23
4
Jeffry R. Keyes
16 May 23
4
Michael Mina
16 May 23
3
Jeffry R. Keyes
16 May 23
4
Scott Mendel
16 May 23
3
Scott Mendel
16 May 23
4
MICHAEL P MCKENNA
17 Mar 23
4
PATRICK SCHNEIDER
17 Mar 23
4
Christian LaPointe
17 Mar 23
4
Claudia Drayton
17 Mar 23
4
JONATHAN M ROTHBERG
9 Mar 23
SC 13G/A
GLENVIEW CAPITAL MANAGEMENT, LLC
14 Feb 23
SC 13G/A
ARK Investment Management LLC
10 Feb 23
SC 13G
BlackRock Inc.
3 Feb 23
4
Grace Johnston
18 Jan 23
4
KEVIN RAKIN
22 Dec 22
3
Grace Johnston
22 Dec 22
4
KEVIN RAKIN
16 Dec 22